Benzinga | Aug 6, 2020 04:02PM EDT

GW Pharmaceuticals Q3 EPS $(0.02) May Not Compare To $(0.63) Estimate, Sales $121.30M Beat $120.31M Estimate

GW Pharmaceuticals (NASDAQ:GWPH) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.63) by 96.83 percent. This is a 66.67 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $121.30 million which beat the analyst consensus estimate of $120.31 million by 0.82 percent. This is a 68.38 percent increase over sales of $72.04 million the same period last year.